Italia markets closed

Mirati Therapeutics, Inc. (MRTX)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
86,37+5,92 (+7,36%)
Alla chiusura: 04:00PM EDT
88,80 +2,43 (+2,81%)
Dopo ore: 04:45PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente80,45
Aperto81,10
Denaro83,80 x 1400
Lettera93,83 x 1100
Min-Max giorno81,10 - 87,46
Intervallo di 52 settimane32,96 - 195,99
Volume672.235
Media Volume1.634.687
Capitalizzazione5,073B
Beta (5 anni mensile)0,99
Rapporto PE (ttm)N/D
EPS (ttm)-11,96
Prossima data utili07 nov 2022 - 11 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A118,46
  • GlobeNewswire

    (MRTX) Alert: Did You Lose Money on Your Mirati Therapeutics Investment? Contact Johnson Fistel Regarding Investigation

    SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Mirati Therapeutics, Inc. (NASDAQ: MRTX) for violations of federal securities laws. On November 1, 2021, Mirati, in an SEC filing, disclosed that certain executives would no longer be serving in their positions. In the filing, the Company stated, “On October 28, 2021, it was determined that Daniel R. Faga would cease serving as the Executive Vice President, Chie